By Abhay Ray 
Introduction
Apollo Hospitals Enterprise Ltd (AHEL) has announced a strategic reorganization to separate its fast-growing pharmacy distribution and digital health businesses from its core hospital operations. As part of this move, AHEL will demerge these businesses into a new entity—tentatively called Apollo HealthTech Ltd (NewCo). This new company will consolidate Apollo 24/7 (its digital health platform) and Keimed (its pharmacy supply chain and distribution arm), creating an integrated, omni-channel healthcare delivery platform.
The demerger aims to unlock shareholder value, enhance transparency, and allow each business to pursue focused growth strategies. NewCo will be independently listed on the stock exchanges within 18–21 months, pending regulatory and shareholder approvals.
About Apollo Hospitals
Apollo Hospitals, India’s first corporate hospital, is recognised as a leader in the private healthcare space in the country, founded by Prathap C. Reddy in 1983 Over the years, it has evolved into India’s leading integrated healthcare services provider. It has a comprehensive presence across the healthcare ecosystem – hospitals, pharmacies, primary care, diagnostic clinics, as well as various retail health formats.
The company operates a total of 10,134 beds across 73 hospitals in India and overseas. Of these, 8,709 beds, in 45 hospitals, are owned by the company, 639 beds are in day surgery centres and cradles, and 790 beds are managed through operations and management contracts in 6 hospitals.
All About Apollo Hospital’s Demerger
Demerger Approval
On 1 July 2025, the board of Apollo Hospitals Enterprise Ltd (AHEL) granted in-principle approval for a Composite Scheme of Arrangement, paving the way for the demerger of its pharmacy distribution and digital health verticals.
The scheme proposes the separation of Apollo HealthCo—housing the pharmacy distribution and digital platforms—into a newly formed listed entity.
Demerger Plan
As per the scheme, AHEL will demerge its omnichannel pharmacy distribution and Apollo 24/7 digital health platform, currently under Apollo HealthCo, into a new company named Apollo Healthtech.
This entity will also include:
- Keimed, AHEL’s wholesale pharma distribution subsidiary
- Apollo’s telehealth services
- Apollo 24/7 and offline retail pharmacy operations
In addition, Apollo Healthtech will become an Indian Owned and Controlled Company (IOCC) and will apply for listing on Indian stock exchanges. AHEL will retain a 15% stake in the new company to ensure integration and continuity of the broader Apollo ecosystem.
The scheme also proposes that Apollo Healthtech will consolidate the front-end pharmacy business by acquiring the remaining 74.5% stake in Apollo Medicals (AMPL), which in turn owns 100% of APL.
Demerger Ratio, Rationale and Timeline
As per the terms of the demerger, shareholders of AHEL will receive 195.2 shares of Apollo Healthtech for every 100 shares held in Apollo Hospitals Enterprise Ltd. This share entitlement structure is designed to allow existing shareholders direct participation in the growth and value creation of Apollo Healthtech.
Apollo’s decision to demerge its pharmacy and digital health businesses is to unlock value and give each segment the space it needs to thrive independently. The move is designed to bring greater focus and flexibility to both the hospital and consumer health verticals.
Chairman Dr Prathap C. Reddy explained that the new entity will carry forward Apollo’s longstanding mission of making world-class healthcare accessible to all, especially the digitally savvy generation. By separating the pharmacy and digital verticals, the company aims to build a customer-centric, omnichannel healthcare platform that can scale rapidly and serve a wider population base. Managing Director Suneeta Reddy highlighted that this reorganisation will allow both businesses to pursue independent growth strategies. With separate leadership, capital plans, and execution strategies, each arm can move faster and with more purpose—while still benefiting from the strength and trust of the Apollo name.
The demerger process, including regulatory and shareholder approvals, is expected to culminate in a stock exchange listing of Apollo Healthtech within 18 to 21 months. AHEL will declare a record date to determine eligible shareholders for the entitlement of Apollo Healthtech shares. Upon completion, Apollo Healthtech shares will be listed on the NSE and BSE. The specific listing date will be announced in due course.
What Shareholders Should Do
- Track Progress: Monitor company updates on SEBI, NCLT, and shareholder approvals for the demerger.
- Understand the Swap: For every 100 Apollo Hospitals shares, you’ll receive 195.2 shares in the new digital-pharmacy entity (NewCo).
- Review Tax Implications: The transaction is likely tax-neutral,but consult your financial advisor for specifics.
- Reassess Portfolio: Post-demerger, you’ll hold two stocks—Apollo Hospitals (core healthcare) and NewCo (digital health/pharmacy). Adjust based on your risk and growth preferences.
- Stay Updated on Listing: NewCo will be listed within 18–21 months; watch for valuation trends and performance before making sell/hold decisions.
Conclusion
Apollo Hospitals’ strategic demerger marks a significant step toward unlocking value and sharpening focus across its businesses. By separating its high-growth pharmacy distribution and digital health platforms into Apollo Healthtech, the group aims to foster independent, agile growth with dedicated leadership and capital strategies. Shareholders benefit through direct exposure to both the stable hospital operations and the high-potential digital-health venture. With a clear share entitlement ratio (195.2:100), transparent timelines, and a commitment to long-term scalability, the reorganization aligns with Apollo’s mission of making accessible, tech-enabled healthcare a reality. Investors should stay informed, evaluate portfolio alignment, and prepare for value creation through dual ownership.
GetMyIndia.com RaysVeda.com LawCanal.com Angeltors.com GMICapitals.com